A multicohort trial of the safety and efficacy of the PD-1 inhibitor MK-3475 in patients with hematologic malignancies.
暂无分享，去创建一个
M. Dolled-Filhart | K. Emancipator | P. Zinzani | G. Garcia-Manero | G. Martinelli | P. Armand | V. Ribrag | R. Iannone | C. Moskowitz | D. Avigan | S. Rose | Dianna Y. Wu | J. Zeidner | R. Geschwindt | C. Gause | H. Brown | K. Anderson